To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.
Clinical trial NCT03123653 · UNKNOWN
Trial details
- NCT number
- NCT03123653
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2019-09-17
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.